Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)

• Status: Unknown status
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study we intend to evaluate and compare the outcomes of intravitreal avastin versus avastin and triamcinolone on improving the visual acuity and macular edema and late complications of CRVO like NVI and NVG.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Bevacizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• CRVO with duration less than 6 months

Exclusion Criteria:

• vision less than 20/320 and vison more than 20/50

• history of galucoma and diabetic retinopathy

• previous laser or intravitreal treatment

• any media opacity that prevents funduscopy